Projects

ICMR proposal Id: IIRPIG-2023-0001239. Establishing the role of relative exchangeable copper in the clinical practice for managing patients with Wilson’s disease. A multi-centric study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2028

Project Lead

ICMR 2025

Authors

Dr. Harshad Devarbhavi & Dr. Mallikarjun

Project Status

ongoing